Patents by Inventor Brigitte KRENN

Brigitte KRENN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140377308
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: August 25, 2014
    Publication date: December 25, 2014
    Inventors: Julia ROMANOVA, Andrej EGOROV, Brigitte KRENN, Markus WOLSCHEK, Sabine NAKOWITSCH
  • Patent number: 8883479
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: November 11, 2014
    Assignee: Baxter Healthcare SA
    Inventors: Brigitte Krenn, Markus Wolschek, Julia Romanova, Andrej Egorov, Sabine Nakowitsch
  • Patent number: 8815252
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: August 26, 2014
    Assignee: Baxter Healthcare SA
    Inventors: Julia Romanova, Andrej Egorov, Brigitte Krenn, Markus Wolschek, Sabine Nakowitsch
  • Publication number: 20110223199
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: November 25, 2009
    Publication date: September 15, 2011
    Applicant: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG
    Inventors: Julia Romanova, Andrej Egorov, Brigitte Krenn, Markus Wolschek, Sabine Nakowitsch
  • Publication number: 20100172934
    Abstract: The present invention provides a method for producing pH-stable enveloped viruses wherein said viruses are used for infection of host cells under low pH conditions and for incubation with cell culture cells under conditions of low pH, as well as influenza viruses obtainable by this method which exhibit a high growth rate in cell culture, increased pH and temperature stability and which have human receptor specificity.
    Type: Application
    Filed: November 25, 2009
    Publication date: July 8, 2010
    Applicant: AVIR Green Hills Biotechnology Research Developmen Trade AG
    Inventors: Brigitte KRENN, Markus WOLSCHEK, Julia ROMANOVA, Andrej EGOROV, Sabine Nakowitsch